Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?
NCT04124939 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2024-04-17
Summary
The purpose of this research study is to help determine if 10 injections of Botox ® 100 units is less painful than 20 injections of Botox ® 100 units based on effectiveness in reducing urge incontinence episodes. Study will also be assessed for the pain of procedure and adverse outcomes of 20 injections versus 10 injections.
Conditions
Interventions
- DRUG
-
OnabotulinumtoxinA 100 Units
BOTOX for injection is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for: • Treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency, in adults who have an inadequate response to or are intolerant of an anticholinergic medication.
Sponsors & Collaborators
-
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Catherine Matthews, MD · Wake Forest University Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-10
- Primary Completion
- 2022-11-09
- Completion
- 2023-02-23
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Randomized Trial for Botox Urinary Incontinence
NCT00178191 ·Status: COMPLETED ·Phase: NA
-
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
NCT01945489 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence
NCT04984317 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)
NCT02097121 ·Status: TERMINATED ·Phase: PHASE3
-
BOTOX® at the Time of Prolapse Surgery for OAB
NCT04807920 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
NCT01852045 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity
NCT01852058 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections
NCT06695585 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Oral vs Intravesical Analgesia for Office Bladder Botox Injections
NCT03755089 ·Status: UNKNOWN ·Phase: PHASE4
-
Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females
NCT01042119 ·Status: COMPLETED
-
Optimal Injection Interval for Intra-Detrusor Botulinum Toxin
NCT06483217 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Reduction in Number of Botox Injections for Urgency Urinary Incontinence
NCT04731961 ·Status: RECRUITING ·Phase: NA
-
Reduced-dose Botox for Urgency Incontinence Among Elder Females
NCT05512039 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Refractory Urge Incontinence and Botox Injections
NCT00373789 ·Status: TERMINATED ·Phase: PHASE3
-
Intravesicular Onabotulinumtoxin A in Interstitial Cystitis
NCT02297100 ·Status: COMPLETED ·Phase: PHASE4
-
Trigonal vs Non Trigonal Botox Injection in OAB.
NCT03533062 ·Status: COMPLETED ·Phase: NA
-
Xeomin vs Botox for Treatment of Overactive Bladder Syndrome
NCT06034288 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence
NCT03052764 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Repris Needle in Bladder Injection
NCT04982120 ·Status: UNKNOWN ·Phase: NA
-
Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
NCT00910520 ·Status: COMPLETED ·Phase: PHASE3
-
516-BOTOX Urinary Incontinence Detrusor
NCT00850733 ·Status: COMPLETED
-
A Research Study for Patients With Overactive Bladder
NCT00168454 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder
NCT02995967 ·Status: TERMINATED ·Phase: NA
-
Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
NCT00910845 ·Status: COMPLETED ·Phase: PHASE3
-
Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder
NCT02557971 ·Status: COMPLETED